Intraumbilical vein injection of oxytocin and the third stage of labor

Randomized double-blind placebo trial

Labib M. Ghulmiyyah, Salim A. Wehbe, Steven L. Saltzman, Carol Ehleben, Baha M. Sibai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The objective of this study was to determine whether intraumbilical injection of oxytocin shortens the third stage of labor. A randomized, double-blind, placebo-controlled trial was used to assess the effectiveness of an intraumbilical injection of oxytocin on the duration of the third stage. Following randomization, each of 79 women received 30 mL of saline (n = 40) or 20 U of oxytocin in 30 mL of saline (n = 39). The primary outcome of interest was the effect on the duration of the third stage. Secondary outcomes examined were change in hemoglobin and percentage of undelivered placenta after 15 minutes. There was no difference in the duration of the third stage between the two groups (7.8 ± 6.1 min in the saline-only group versus 5.9 ± 2.6 min in the oxytocin group). The change in hemoglobin was significantly lower in the oxytocin group (1.3 ± 0.9 g/dL in the oxytocin group versus 1.8 ± 0.9 g/dL in the saline-only group). The percentage of undelivered placentas beyond 15 minutes was significantly lower in the oxytocin group (0% in the oxytocin group versus 12.5% in the saline-only group). The study concluded that intraumbilical vein injection of oxytocin reduced the rate of placentas remaining undelivered beyond 15 minutes and subsequent blood loss.

Original languageEnglish (US)
Pages (from-to)347-351
Number of pages5
JournalAmerican Journal of Perinatology
Volume24
Issue number6
DOIs
StatePublished - Jun 2007
Externally publishedYes

Fingerprint

Third Labor Stage
Oxytocin
Veins
Placebos
Injections
Placenta
Hemoglobins
Random Allocation

Keywords

  • Intraumbilical vein injection
  • Retained placenta
  • Third stage of labor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Intraumbilical vein injection of oxytocin and the third stage of labor : Randomized double-blind placebo trial. / Ghulmiyyah, Labib M.; Wehbe, Salim A.; Saltzman, Steven L.; Ehleben, Carol; Sibai, Baha M.

In: American Journal of Perinatology, Vol. 24, No. 6, 06.2007, p. 347-351.

Research output: Contribution to journalArticle

Ghulmiyyah, Labib M. ; Wehbe, Salim A. ; Saltzman, Steven L. ; Ehleben, Carol ; Sibai, Baha M. / Intraumbilical vein injection of oxytocin and the third stage of labor : Randomized double-blind placebo trial. In: American Journal of Perinatology. 2007 ; Vol. 24, No. 6. pp. 347-351.
@article{d3d242915dbc4941a6e783a33d2d78a8,
title = "Intraumbilical vein injection of oxytocin and the third stage of labor: Randomized double-blind placebo trial",
abstract = "The objective of this study was to determine whether intraumbilical injection of oxytocin shortens the third stage of labor. A randomized, double-blind, placebo-controlled trial was used to assess the effectiveness of an intraumbilical injection of oxytocin on the duration of the third stage. Following randomization, each of 79 women received 30 mL of saline (n = 40) or 20 U of oxytocin in 30 mL of saline (n = 39). The primary outcome of interest was the effect on the duration of the third stage. Secondary outcomes examined were change in hemoglobin and percentage of undelivered placenta after 15 minutes. There was no difference in the duration of the third stage between the two groups (7.8 ± 6.1 min in the saline-only group versus 5.9 ± 2.6 min in the oxytocin group). The change in hemoglobin was significantly lower in the oxytocin group (1.3 ± 0.9 g/dL in the oxytocin group versus 1.8 ± 0.9 g/dL in the saline-only group). The percentage of undelivered placentas beyond 15 minutes was significantly lower in the oxytocin group (0{\%} in the oxytocin group versus 12.5{\%} in the saline-only group). The study concluded that intraumbilical vein injection of oxytocin reduced the rate of placentas remaining undelivered beyond 15 minutes and subsequent blood loss.",
keywords = "Intraumbilical vein injection, Retained placenta, Third stage of labor",
author = "Ghulmiyyah, {Labib M.} and Wehbe, {Salim A.} and Saltzman, {Steven L.} and Carol Ehleben and Sibai, {Baha M.}",
year = "2007",
month = "6",
doi = "10.1055/s-2007-981854",
language = "English (US)",
volume = "24",
pages = "347--351",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Intraumbilical vein injection of oxytocin and the third stage of labor

T2 - Randomized double-blind placebo trial

AU - Ghulmiyyah, Labib M.

AU - Wehbe, Salim A.

AU - Saltzman, Steven L.

AU - Ehleben, Carol

AU - Sibai, Baha M.

PY - 2007/6

Y1 - 2007/6

N2 - The objective of this study was to determine whether intraumbilical injection of oxytocin shortens the third stage of labor. A randomized, double-blind, placebo-controlled trial was used to assess the effectiveness of an intraumbilical injection of oxytocin on the duration of the third stage. Following randomization, each of 79 women received 30 mL of saline (n = 40) or 20 U of oxytocin in 30 mL of saline (n = 39). The primary outcome of interest was the effect on the duration of the third stage. Secondary outcomes examined were change in hemoglobin and percentage of undelivered placenta after 15 minutes. There was no difference in the duration of the third stage between the two groups (7.8 ± 6.1 min in the saline-only group versus 5.9 ± 2.6 min in the oxytocin group). The change in hemoglobin was significantly lower in the oxytocin group (1.3 ± 0.9 g/dL in the oxytocin group versus 1.8 ± 0.9 g/dL in the saline-only group). The percentage of undelivered placentas beyond 15 minutes was significantly lower in the oxytocin group (0% in the oxytocin group versus 12.5% in the saline-only group). The study concluded that intraumbilical vein injection of oxytocin reduced the rate of placentas remaining undelivered beyond 15 minutes and subsequent blood loss.

AB - The objective of this study was to determine whether intraumbilical injection of oxytocin shortens the third stage of labor. A randomized, double-blind, placebo-controlled trial was used to assess the effectiveness of an intraumbilical injection of oxytocin on the duration of the third stage. Following randomization, each of 79 women received 30 mL of saline (n = 40) or 20 U of oxytocin in 30 mL of saline (n = 39). The primary outcome of interest was the effect on the duration of the third stage. Secondary outcomes examined were change in hemoglobin and percentage of undelivered placenta after 15 minutes. There was no difference in the duration of the third stage between the two groups (7.8 ± 6.1 min in the saline-only group versus 5.9 ± 2.6 min in the oxytocin group). The change in hemoglobin was significantly lower in the oxytocin group (1.3 ± 0.9 g/dL in the oxytocin group versus 1.8 ± 0.9 g/dL in the saline-only group). The percentage of undelivered placentas beyond 15 minutes was significantly lower in the oxytocin group (0% in the oxytocin group versus 12.5% in the saline-only group). The study concluded that intraumbilical vein injection of oxytocin reduced the rate of placentas remaining undelivered beyond 15 minutes and subsequent blood loss.

KW - Intraumbilical vein injection

KW - Retained placenta

KW - Third stage of labor

UR - http://www.scopus.com/inward/record.url?scp=34447274745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447274745&partnerID=8YFLogxK

U2 - 10.1055/s-2007-981854

DO - 10.1055/s-2007-981854

M3 - Article

VL - 24

SP - 347

EP - 351

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 6

ER -